Treatment interruption
Sponsors
National Institute of Allergy and Infectious Diseases (NIAID), University Hospital, Geneva, French National Agency for Research on AIDS and Viral Hepatitis, SEARCH Research Foundation
Conditions
AIDSAcute HIV InfectionAntiretroviral Treatment InterruptionHIV InfectionHIV Infections
Phase 2
A Study to Demonstrate That Anti-HIV Drug Therapy Can be Stopped Without Causing Viral Resistance, and to Characterize Drug Elimination From the Body
CompletedNCT00029341
Target: 36Updated: 2008-07-30
Phase II/III Study Evaluating the Effect of IL-2 on Preservation of the CD4 T-Lymphocytes After Interruption of Antiretroviral Treatment in HIV-Infected Patients With CD4 T-Lymphocyte Count Greater Than 500 Cells/mm3 Who Received Antiretroviral Tx
CompletedNCT00071890
Start: 2003-10-31End: 2007-12-31Updated: 2010-10-05
Phase 3
Unknown Phase
Staccato: A Trial of CD4 Guided Treatment Interruption, Compared to Continuous Treatment, for HIV Infection
CompletedNCT00113126
Start: 2002-01-31End: 2005-10-31Target: 526Updated: 2006-11-29
Viral Suppression After Analytic Treatment Interruption in Thai Patients Who Initiated Highly Active Antiretroviral Therapy During Acute HIV Infection
CompletedNCT02614950
Start: 2016-02-29End: 2016-12-31Updated: 2017-01-27